Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

The global active pharmaceutical ingredients market size was worth USD 239.18 billion in 2024 and is expected to reach around USD 368.49 billion by 2033, with a noteworthy CAGR of 5.64% from 2023 to ...

The study was a meta-analysis based on a systematic review of the literature to identify patients with FH. A total of 360 FH cases (246 FH type I, 73 type II, 29 type III and 12 type IV) and 830 ...

Endo, Inc. (OTCQX: NDOI) announced today the launch of its newest television commercial and disease awareness campaign, I Got Somebody. The campaign aims to motivate men who may have symptoms of ...

Glycemic control improved among patients with diabetes who received layperson-delivered telephone-based empathetic engagement vs usual care.

There's a boom in the use of weight loss medications with more new ones on their way, but they are recommended only for the clinically obese. A slew of new weight loss drugs are being tested in 2025.

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...

On in the Dutchman’s place was Endo but he was on the receiving end of a high challenge from Julio Enciso, who himself was a second half substitute. The Ipswich debutant was shown a yellow card ...

AUSTIN, TX / ACCESS Newswire / February 10, 2025 / After one year of John Kim at the helm of Volcon ePowersports, their ...

Teruki Endo, leading the panel, will discuss the challenges in undertaking required to implement it. The panel is open to anyone attending GDC 2025 with an interest in creating games with combat ...

Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women with type 2 diabetes and osteoporosis.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at ...